This finding is consistent with previous observations that Igf‐2R promoted endocytosis and lysosomal degradation of Igf‐2, thereby antagonizing its action and acting as a tumor suppressor protein (Brown et al., 2009). This evidence concerns the gene IGF2 and neoplasm.